Constitutive heterochromatin is important for maintaining chromosome stability but also delays the repair of DNA double strand breaks (DSB). DSB repair in complex mammalian genomes involves a fast phase (2-6 hrs) where most of the breaks are rapidly repaired, and a slow phase (up to 24 hrs) where the remaining damages in heterochromatin are repaired. We found that p53 deficiency delays the slow phase DNA repair after ionizing irradiation. P53 deficiency prevents down regulation of histone H3K9 trimethylation at pericentric heterochromatin after DNA damage. Moreover, p53 directly induces expression of the H3 K9 demethylase JMJD2b through promoter binding. P53 activation also indirectly down regulates expression of the H3 K9 methytransferase SUV39H1. Depletion of JMJD2b or sustained expression of SUV39H1 delays the repair of heterochromatin DNA and reduces clonogenic survival after ionizing irradiation. The results suggest that by regulating JMJD2b and SUV39H1 expression, p53 not only controls transcription but also promotes heterochromatin relaxation to accelerate a rate-limiting step in the repair of complex genomes.
Introduction
Different tumor types have variable response to ionizing radiation (IR). Long-term survival after IR has been shown to correlate with efficient DNA repair. P53 is highly inducible by IR through ATM-dependent inhibition of the MDM2 E3 ligase (1) . P53 stabilization induces cell cycle arrest in most epithelial and mesenchymal cell types, and induces apoptosis in lymphocytes or proliferating cells of the intestine.
Users may view, print, copy, download and text and data-mine the content in such documents, for the purposes of academic research, subject always to the full Conditions of use: http://www.nature.com/authors/editorial_policies/license.html#terms P53-null mice are sensitive to IR-induced tumorigenesis, suggesting that p53 is involved in DSB repair (2) . Inactivation of p53 leads to chromosomal instability during tumor development in mouse models (3) . P53-null MEFs become aneuploid after only a few passages in culture, indicating a significant defect in chromosome segregation (4) . Fibroblasts from patients with Li-Fraumeni syndrome (germ line heterozygous p53 mutation) also have chromosome instability in culture (5) . Bone marrow and spleen cells in p53-null mice show higher levels of chromosome abnormalities in the absence of any treatment, suggesting that p53 function is important for maintaining genomic stability under physiological conditions (6) . P53 deficiency leads to increased homologous recombination in vivo and in vitro (7, 8) . The potential of p53 in regulating multiple DNA repair pathways were generally explained by its ability to regulate the expression of genes directly involved in the DNA repair process, or by direct binding of p53 to DNA repair factors (9, 10) .
The biological outcome of p53 activation (arrest, apoptosis, senescence) is dependent on cell type and stimuli. The p53 pathway is compromised to different degrees in all tumors, including partial to complete loss-of-function mutations, gain-of-function mutations, and functional inactivation by MDM2. While loss of wild type p53 activity per se may increase radio sensitivity, most tumors accumulate gain-of-function mutant p53 that increase resistance to DNA damage (11) . The combination of these diverse and conflicting effects confounds earlier efforts to determine the prognostic value of p53 status in treatment response. The role of p53 in tumor sensitivity to radiation is controversial in clinical studies (12, 13) . Wild type p53 has been reported to associate with favorable or unfavorable treatment response, or having no impact.
Numerous studies suggest that epigenetic marks on chromatin are important determinants of genomic stability and DNA repair efficiency. DNA double strand break repair involves a fast phase (2-6 hrs) when ~80% of the breaks are rapidly repaired, and a slow phase (up to 24 hrs) when the remaining damages are repaired. Completion of the slow phase repair specifically requires ATM signaling (14) . Recent studies showed that DSB repaired during the slow phase are localized in constitutive pericentric heterochromatin (HC) regions of the genome (15) . Although IR induces similar rate of DSB formation in heterochromatin and euchromatin (16) , IR induces fewer γH2AX foci in heterochromatin shortly after IR (17) , and these foci are cleared at a slower rate. Heterochromatin formation inhibits DSB repair by limiting access of repair factors to the breaks, and preventing chromatin remodeling near the break. It has been shown that mammalian cells with reduced linker histone H1 and more accessible chromatin are less sensitive to IR (18) . ATM phosphorylation of the chromatinmodifying factor KAP1 promotes chromatin relaxation and efficient repair of heterochromatin DSB (19, 20) . Study in Drosophila cells showed that heterochromatin domains become more mobile and expanded after IR, DSB foci in repetitive sequences relocate outside of the heterochromatin domain before being repaired by homologous recombination mechanism (21) .
transcripts (23) . SUV39H1/2 are also important for H3 K9me3 modification at telomeric heterochromatin. SUV39H1/2 deficiency leads to abnormal elongation of telomeres (24) . MEFs derived from SUV39H1/2 double-null mice have significant chromosome missegregation and rapidly become aneuploid in culture (22) . Drosophila embryos with Su(var)3-9 deficiency also have chromosome defects and spontaneous DNA damage in heterochromatin (25) . Therefore, SUV39H1 is important for heterochromatin maintenance, and regulates the efficiency of DSB repair. The Jumonji domain 2 (JMJD2) family demethylase JMJD2b removes pericentric heterochromatin K9m3 marks, thus opposes the function of SUV39H1 (26) . JMJD2b is overexpressed in breast tumors with chromosome instability. Overexpression of JMJD2b in cell lines also increases chromosome instability (27) .
In this report, we show that p53 is required for down-regulation of H3 K9me3 level in pericentric heterochromatin after IR. P53 deficiency causes significant delay in the slow phase repair. To explore the mechanism, we found that p53 activates JMJD2b expression and represses SUV39H1. These results suggest that p53 induces relaxation of heterochromatin by regulating the enzymes involved in H3 K9 methylation. Therefore, regulation of JMJD2b and SUV39H1 level by p53 not only controls gene expression, but also facilitates the repair of damaged heterochromatin DNA, which is a rate-limiting step in global DNA repair of complex genomes.
Results p53 inactivation delays heterochromatin DNA repair after IR
Previous study showed that p53 knockout in HCT116 reduces cell survival after IR (28) . We also reported that p53 knockdown or overexpression of MDM2 in U2OS reduces colony formation after IR (29) . However, the mechanisms of these observations were unclear. To test whether DNA repair plays a role, HCT116 and HCT116-p53−/− cells were analyzed for γH2AX level by western blot after IR, since γH2AX foci formation is a sensitive marker for the presence of DSB (30) . IR treatment induced rapid increase of γH2AX in both cell lines. The γH2AX level returned to background after 24 hours in parental HCT116 cells, but remained significantly above background in HCT116-p53−/− at 24 and 48 hours after IR (Figure 1a) . IR induced JMJD2b expression and suppressed SUV39H1 level in a p53-dependent fashion (Figure 1a , further addressed below). Transient knockdown of p53 in A549 cells also delayed the down regulation of γH2AX after IR, although the effect was moderate due to incomplete depletion of p53 (Figure 1b) . Immunofluorescence staining of γH2AX showed significant number of DNA damage foci remaining in p53-null cells 48 hours after IR (Figure 1c, 1d) . These results suggest that p53 deficiency prevents the timely repair of damaged DNA.
p53 promotes the repair of heterochromatin DNA
Since heterochromatin DNA is often repaired during the slow phase (15), we hypothesized that the γH2AX present in p53-null cells at late time points after IR may be associated with heterochromatin regions. We performed γH2AX ChIP analysis to compare the constitutive heterochromatin repair efficiency between HCT116 and HCT116-p53−/− cells. Cells were treated with 5 Gy IR and γH2AX ChIP was PCR amplified using D5Z1 primers specific for Chromosome 5 and 19 alpha satellite tandem repeats (27, 31) , and primers that detect interspersed repetitive elements LINE-1 and Alu. As expected, the levels of alpha satellite, LINE-1, and Alu DNA pulled down by γH2AX ChIP remained elevated 42 hours after IR in HCT116-p53−/− cells, but largely returned to near-background levels in wild type HCT116 (Figure 2a, 2b, 2c ). Attempts to analyze γH2AX ChIP signal on euchromatin were unsuccessful due to the extremely low probability of DNA strand breaks occurring in any single copy gene (~100 DSB/cell after 5 Gy IR). Overall, these results suggest that p53 is important for promoting the repair of damaged DNA in heterochromatin.
p53 down regulates heterochromatin H3 K9 methylation after IR
Recently, we found that the p53 transcription target MDM2 interacts with SUV39H1 (32), which is an enzyme important for H3 K9 trimethylation in pericentric heterochromatin. Furthermore, it was reported that MDM2 can ubiquitinate and degrade SUV39H1 (33) . However, previous studies showed that DNA damage treatments do not reduce total H3 K9me3 level in human cell lines (19, 34) . We also failed to detect robust decrease in bulk H3 K9me3 level after IR (Figure 6a ). To test whether p53 activation specifically reduces H3 K9 methylation level in constitutive heterochromatin, HCT116 and HCT116-p53−/− cells were treated with IR and analyzed by H3 K9me3 and H3 K9me2 ChIP after 24 hours. IR treatment led to ~70% reduction of K9me3 level in pericentric alpha satellite DNA in HCT116 but not HCT116-p53−/− cells (Figure 3a) . In addition to the pericentromeric tandem repeats, interspersed transposable elements (LINE, SINE, LTR, etc) are also mostly present in silenced states (35, 36) . We found that LINE-1 and Alu repeats also have decreased H3 K9me3 level after IR (Figure 3b , 3c), although less significant than alpha satellite repeats presumably due to some presence near active genes. H3 K9me3 level at the GAPDH promoter did not show significant changes (Figure 3d ). ChIP analysis of H3 K9me2 level also showed a similar trend as K9me3 (data not shown). Transient knock down of p53 in A549 cells also abrogated the down regulation of H3 K9me3 level at pericentric heterochromatin (Supplemental Figure 1) . Therefore, p53 promotes the down-regulation of heterochromatin H3 K9 methylation after DNA damage.
p53 activates JMJD2b expression and represses SUV39H1
To identify the mechanism of H3 K9me3 down regulation by p53, we tested whether the JMJD2 family of H3 K9 demethylases mediates the effect of p53 (26) . We found that JMJD2b was induced by p53 at both protein and mRNA levels after IR and Nutlin treatments ( Figure 1a, Figure 4a , 4b). In contrast, JMJD2a mRNA was not significantly induced by p53 (Figure 4c) . A recent report showed that the p53-inducible E3 ligase MDM2 causes SUV39H1 degradation (33) . Therefore, we tested whether p53 down regulates SUV39H1 through MDM2 induction. When U2OS and A549 cells were treated with IR, Nutlin or low dose actinomycin D, significant down regulation of SUV39H1 was observed (Figure 4d ), correlating with p53 activation. In contrast, SUV39H1 level remained unchanged in p53-deficient H1299 and U2OS-E6 cells (Figure 4d , lower panels). Therefore, p53 activation regulates multiple enzymes that control H3 K9 methylation.
If SUV39H1 down regulation was due to degradation by MDM2, treatment with proteasome inhibitor should restore SUV39H1 level. However, we did not observe such rescue using MG132 (data not shown). Furthermore, we tested directly whether MDM2 overexpression can promote ubiquitination and degradation of SUV39H1 in cotransfection and failed to detect a reproducible effect (data not shown). RT-PCR analysis showed that SUV39H1 mRNA level was significantly reduced after activation of p53 (Figure 4e ). The turnover rate of SUV39H1 mRNA after transcription block by high-dose actinomycin D was not affected by p53 activation (Supplemental Figure 2) . Therefore, the loss of SUV39H1 was due to reduced transcription.
JMJD2b is a direct transcriptional target of p53
Since p53 induces JMJD2b expression at the mRNA level, we tested whether JMJD2b is a direct target of p53. Sequence analysis of the JMJD2b promoter revealed a putative p53 binding site located at −450 bp from the transcription start site, which contains two half sites without spacer [GCACCTGCCC CAGCCTGTCC. Underlined residues conform to p53 binding half site consensus: 5′-PuPuPuC(A/T)(T/A)GPyPyPy-3′] (37). Therefore, we cloned a 1 kb fragment of the JMJD2b promoter and tested its response to p53 in luciferase reporter assay. The JMJD2b promoter was activated by p53 (~3 fold) in cotransfection assay as expected ( Figure 5a ). Furthermore, point mutations in the putative p53 binding site abrogated responsiveness to p53 (Figure 5b ). P53 ChIP of HCT116 and HCT116-p53−/− cells confirmed that endogenous p53 binds to the JMJD2b promoter in vivo at −0.5 kb but not to a region at −1.8 kb from the transcription start site (Figure 5c ), suggesting that JMJD2b is a bona fide target gene of p53.
P53 down regulates the transcription of many genes indirectly through inducing p21, which in turn activates the retinoblastoma protein and inhibits E2F transcription factors (38) . When p21 was transiently transfected into H1299 cells, SUV39H1 expression was reduced ( Figure  5d ). Furthermore, when p27 was overexpressed in U2OS using tetracycline-inducible system, the cells undergoing G1 arrest also showed significant reduction of SUV39H1 (Figure 5e ). We cloned the SUV39H1 promoter and found that it was activated by E2Fs in luciferase reporter assay (Figure 5f ). These results suggest that p53 down regulates SUV39H1 through inducing p21 and repressing E2F activity.
Constitutive SUV39H1 expression delays DNA repair and reduces survival
To test whether SUV39H1 down regulation by p53 is important for DNA repair and cell survival, we generated U2OS cells expressing Tet-inducible SUV39H1. Tetracycline treatment maintained total SUV39H1 at close to unstressed level even after DNA damage and p53 activation (Figure 6a ). Sustained SUV39H1 expression led to reduction of colony formation efficiency after IR (Figure 6b, 6c) , whereas the control U2OS-TR cells were not affected by tetracycline. Therefore, SUV39H1 down regulation after DNA damage facilitates long-term survival.
Western blot analysis showed that IR induced rapid γH2AX and p53 S15 phosphorylation irrespective of SUV39H1 induction. However, the down regulation of γH2AX and p53 phosphorylation at 16-32 hour time points after IR were significantly delayed in SUV39H1-expressing cells, indicating a repair deficiency and sustained ATM activation (Figure 7a ). Immunofluoresence staining of γH2AX showed that SUV39H1 expression led to the presence of a significant number of γH2AX foci 40 hours after IR (Figure 7b, 7d) . Therefore, SUV39H1 down regulation is important for the completion of DNA repair.
Sustained p53 phosphorylation in the presence of constitutive SUV39H1 is expected to prevent cell cycle re-entry after DNA damage, and possibly induce cellular senescence. SA-β-gal staining showed that SUV39H1 expression did not increase the number of cells displaying senescence phenotype before and after irradiation (Supplemental Figure 3) . Following IR treatment, U2OS cells showed reduction of 3 H-thymidine incorporation consistent with cell cycle arrest. At 48 and 66 hours after IR, control U2OS cells began to restore DNA synthesis, but SUV39H1 expressing cells remained arrested (Figure 7c ). These results suggest that constitutive SUV39H1 expression prevents timely repair of DSB and causes sustained cell cycle arrest.
Constitutive SUV39H1 inhibits the repair of heterochromatin DNA
DSBs repaired during the slow phase are mostly localized in constitutive heterochromatin (15) . SUV39H1 is involved in H3 K9 tri-methylation at pericentric heterochromatin (22) . Therefore, SUV39H1 down regulation may be necessary for the efficient repair of heterochromatin DNA. To test this hypothesis, U2OS-tet-SUV39H1 cells were treated with 5 Gy IR and γH2AX ChIP was amplified using D5Z1 and D5Z2 primers (both are specific for Chromosome 5 and 19 alpha satellite) (27, 31) . In control cells, the level of γH2AX associated with heterochromatin returned to near-basal level 42 hours after IR, consistent with completion of DSB repair. When SUV39H1 expression was sustained, heterochromatin-associated γH2AX level remained very high 42 hours after IR, suggesting the presence of persistent DNA damage (Figure 8a, 8b) . PCR analysis using primers representing LINE-1 and Alu consensus sequence showed that the repair of DSBs at these repetitive elements were also delayed by constitutive SUV39H1 expression (Figure 8c, 8d) . Therefore, down regulation of SUV39H1 expression is critical for the repair of heterochromatin DSB after IR.
JMJD2b expression facilitates repair of heterochromatin DNA
JMJD2b acts opposite to SUV39H1 in regulating H3 K9 methylation. Since its expression was induced by p53, we tested the effects of JMJD2b knockdown after IR treatment. The results showed that knockdown of JMJD2b by siRNA reduced cell survival after IR in colony formation assay (Figure 9a, 9b) . Furthermore, γH2AX ChIP using alpha satellite primers showed that JMJD2b knockdown delayed the repair of heterochromatin DNA after IR (Figure 9c ). These results are consistent with the interpretation that p53 down regulates SUV39H1 and induces JMJD2b to promote heterochromatin DSB repair and cell survival.
To test whether inhibition of JMJD2b sensitize tumor cells to chemotherapy drugs, U2OS cells were treated with JMJD2b siRNA in combination with several DNA-damaging agents. JMJD2b knockdown by RNAi significantly reduced cell survival after DNA-damaging drug treatment (doxorubicin and etoposide), but had little effect on 5-FU (RNA-targeting drug at 50 μM) (Figure 9d) . Therefore, targeting JMJD2b demethylase activity may be useful in combination with DNA-damaging drugs in cancer treatment.
Discussion
Although p53 mediates acute apoptotic response in rapidly proliferating cells such as thymocytes after irradiation, lose of p53 has been shown to paradoxically reduce long-term viability after IR in certain cell lines. Results described in this report show that p53 deficiency compromises the repair of DNA double strand breaks in constitutive heterochromatin. DNA double strand break triggers chromatin relaxation that involves ATM-dependent phosphorylation of KAP1 (39) (20) . P53 has also been shown to facilitate chromatin decompaction after UV irradiation (40, 41) , but the mechanism was unknown. Our results in this report suggest that p53 induction of JMJD2b and repression of SUV39H1 causes down regulation of H3 K9 trimethylation level at pericentric heterochromatin and interspersed repetitive elements after irradiation, thus promoting heterochromatin relaxation and increasing accessibility to DNA repair factors ( Figure 10 ).
SUV39H1 antagonizes p53 transcriptional function by interacting with MDM2, or directly modifying the chromatin of p53 target genes. Therefore, p53 repression of SUV39H1 should generate a positive feedback. Consistent with this model, results from our lab and a recent study by Mungamuri et al. showed that knockdown of SUV39H1 increase the expression of p53 target genes, whereas overexpression of SUV39H1 inhibits p53 activity (32, 42) . Our current findings suggest that in addition to gene regulation, p53-mediated change in H3 K9 methylation has important functions in facilitating timely repair of DNA strand breaks. Proper condensation of pericentric heterochromatin is important for accurate segregation of sister chromosomes during mitosis. Inactivation of p53 causes abnormal regulation of SUV39H1 and JMJD2b expression, which may lead to chromosome instability in cancer. Telomeric repeats are also rich in H3 K9me3 modification (43) . Mice deficient for SUV39H1/H2 have abnormal telomere length and H3 K9me3 level at telomeric heterochromatin (24) . Although not analyzed in our study, it is likely that p53 also regulates the stability of telomeric heterochromatin. It has been shown that p53-deficient human tumors often have telomere length alterations (44, 45) .
Cells with different radiation sensitivity often show similar level of DSB formation and similar ability to rapidly repair >70% of the DSBs a few hours after damage. Previous studies showed that radio sensitivity correlates with the number of DSB remaining after 24 hours (46). Radio-sensitive tumor cell lines and xenografts retain more γH2AX foci 24 hours after IR (47) . Therefore, radio resistance correlates with the ability of the cells to down regulate γH2AX level 24 hours after IR. Recent studies indicate that DSBs that require up to 24 hours to repair are mostly localized in heterochromatin (15) . IR induces fewer γH2AX foci in heterochromatin in human cells shortly after IR (17) , despite similar rate of DSB in heterochromatin and euchromatin (16) , suggesting that heterochromatin formation delays γH2AX foci assembly or disappearance. By regulating histone methylation at heterochromatin loci, p53 may help to overcome a rate-limiting step in global DNA repair. The DNA repair function of p53 may be particularly important in higher organisms because of increased complexity of their genomes. Up to 50% of human genomic DNA are composed of repetitive sequences, mostly present as silent chromatin with high levels of DNA and histone methylation (48) .
Although p53 activation can cause apoptosis under some conditions, the pro-survival function observed in our experiment is consistent with several previous reports. P53 knockout in HCT116 increased sensitivity to IR and doxorubicin (28) . Ectopic expression of a temperature-sensitive p53 in PC3 cells increased radio resistance in long-term survival assay (49) . P53 wild type tumor cell lines generally show faster γH2AX down regulation after IR compared to p53 deficient cells (50) . Therefore, it is likely that in many cell types, the physiological function of p53 is to promote DNA damage repair and cell survival, which is beneficial to organism fitness. Only severely damaged or rapidly cycling cells commit to apoptosis after p53 activation to reduce the chance of propagating mutations. Although there is no general consensus on the relationship between p53 mutation status and treatment response, in certain narrow setting such as breast cancer, p53 mutation is associated with favorable response to chemotherapy (51) (52) (53) . A recent report showed that in a mouse model wild type p53 also reduced the efficacy of doxorubicin against mammary tumors (54).
Our results showed that p53-mediated cell cycle arrest indirectly represses SUV39H1 expression. In fact, overexpression of p21 or p27 also repressed SUV39H1. During the preparation of this manuscript, Mungamuri et al reported that p53 represses SUV39H1 transcription in a p21-dependent fashion (42) , which is consistent with our finding. Many p53-repressed genes are transcriptional targets of E2F1 and are repressed through p21-mediated regulation of pRb (38) . The SUV39H1 promoter is activated by E2Fs in reporter assay, suggesting that p53 suppresses SUV39H1 by inducing p21 and inactivating E2Fs. It has been reported that the Drosophila JMJD2b homolog is induced by the fly p53 after UV irradiation, leading to reduction in heterochromatin K9me3 level that is important for survival (55) . Our results show that human JMJD2b is also inducible by p53, suggesting that regulation of heterochromatin H3K9 methylation is an important and evolutionarily conserved function of p53.
Activation of p53 has been shown to induce cellular senescence, accompanied by expression of the senescence marker SA-β-gal. The observation that p53 can induce senescence while repressing SUV39H1 important for heterochromatin formation appears self-contradictory. However, previous study showed that p53-dependent senescence is reversible after p53 inactivation (56) . A recent study using Nutlin also showed that p53 only induces a senescence-like phenotype (SA-β-gal positive) in many epithelial tumor cell lines, which is reversible after removal of Nutlin (57) . Therefore, the senescence phenotype induced by p53 is different from the pRb-mediated permanent arrest that involves irreversible silencing of E2F targets and formation of senescence-associated heterochromatin foci (SAHF) (58) . The requirement of SUV39H1 in senescence is also cell type dependent. SUV39H1 is required for senescence by oncogenic ras in mouse splenocytes (59), but Narita et al. found that oncogenic ras can induce senescence in SUV39H1/2 double-null MEFs (58) . Nutlin activation of p53 in epithelial cancer cells does not induce SAHF despite SA-β-gal positive staining (57) . Therefore p53-induced senescence does not involve the level of heterochromatin formation that occurs in irreversible senescent cells. It is quite possible that DNA damage induces rapid mobilization of HP1β on a global scale within minutes (60) (61) (62) . P53-mediated changes of SUV39H1 and JMJD2b levels occur at a slower time scale (hours post damage) and may serve as a second wave response to reinforce the initial changes. P53 has been implicated in regulating multiple DNA repair pathways through regulation of genes involved in the repair or by direct binding to repair factors (9, 10) . The results in this study suggest that p53 also facilitates DNA repair by regulating the levels of enzymes involved in H3 K9 methylation and modifying heterochromatin compaction on a global scale. Because perturbation of SUV39H1 and JMJD2b each has significant impact on DSB repair efficiency, these chromatin modifiers are likely to be important mediators of p53 function in maintaining the stability of highly repetitive DNA sequences.
Materials and methods

Cell lines and reagents
H1299 (non-small cell lung carcinoma, p53 null), U2OS (osteosarcoma, p53 wild-type), U2OS-E6 (U2OS stably infected with retrovirus vector expressing HPV E6), A549 (lung adenocarcinoma, p53 wild-type), and HCT116 (colon carcinoma, p53 wild-type) were maintained in Dulbecco modified Eagle medium (DMEM) with 10% fetal bovine serum. Transfection of H1299 cells was performed using standard calcium phosphate precipitation protocol. U2OS cells with stable expression of SUV39H1 were generated by infection with pLenti-FLAG-SUV39H1 virus followed by Zeocin selection (ViraPower T-REX lentiviral expression system, Invitrogen). Tetracycline-inducible U2OS-HA-p27 cells were generated previously (63) . HCT116-p53−/− cells were provided by Dr. Bert Vogelstein. Racemic Nutlin-3a was purchased from Cayman Chemical Company (Ann Arbor, Michigan). Actinomycin D, 5-FU, doxorubicin and etoposide were purchased from Sigma. JMJD2b promoter-luciferase mutant constructs with altered p53 binding element were generated by site-directed mutagenesis (Wild type p53 binding site: GCACCTGCCCCAGCCTGTCC. M1: GaattCTGCCCCAGCCTGTCC. M2: GCACCaattCCAGCCTGTCC). SA-β-gal staining was performed using a kit from Sigma.
Western blot
Cells were lysed in lysis buffer (50 mM Tris-HCl [pH 8.0], 5 mM EDTA, 150 mM NaCl, 0.5% NP-40, 1 mM phenylmethylsulfonyl fluoride), centrifuged for 10 minutes at 14,000 × g and the insoluble debris was discarded. Cell lysate (10 to 50 μg of protein) was fractionated by sodium dodecyl sulfate (SDS)-polyacrylamide gel electrophoresis and transferred to Immobilion P filters (Millipore). The filter was blocked for 1 h with phosphate-buffered saline (PBS) containing 5% nonfat dry milk and 0.1% Tween 20, incubated with primary and secondary antibodies, and the filter was developed using the Supersignal reagent (Thermo Scientific). MDM2 was detected using antibody 3G9. Antiactin and HA tag antibodies were purchased from Santa Cruz Biotechnology. FLAG tag antibody was from Sigma-Aldrich. Anti-SUV39H1 antibody was from Millipore. Anti-JMJD2B antibody was from Bethyl. DO-1 for p53 was from Pharmingen and Phospho-p53 (Ser15) antibody was from Cell Signaling. Anti-histone H3 (trimethyl K9) and Anti-histone H3 (dimethyl K9) antibodies were from Abcam. Anti-histone H3 antibody, anti-γH2AX and H2AX antibodies were from Upstate.
Luciferase reporter assay
Cells (50,000 per well) were cultured in 24-well plates and transfected with a mixture containing 50 ng luciferase reporter plasmid, 5 ng CMV-lacZ plasmid, 50 ng E2Fs expression plasmids or p53 expression plasmid. Transfection was achieved using Lipofectamine PLUS reagents (Invitrogen). Cell lysate was analysed for luciferase and β-gal expression after 24 h. The ratio of luciferase/β-gal activity was used as an indicator of transcription activity.
Chromatin Immunoprecipitation
Chromatin immunoprecipitation was carried out using a published procedure (64) . Protein-DNA complexes from cells lysate were immunoprecipitated with antibody and protein A agarose/salmon sperm DNA beads (Millipore). Coprecipitated chromatin was analyzed by quantitative PCR using the following primers: 5′-ACGAGGTCAGGAGATCGAGA and 5′-CTCAGCCTCCCAAGTAGCTG for Alu1 (65); 5′-CAGAATCTCTGGGACGCATT and 5′-ATTGTGATGTTCGGGTGTCA for LINE-1 (GenBank entry: X52235.1); 5′-TAGACAGAAATATTCTCACAATCGT and 5′-GCCCTCAAAGCGCTCCAAG for pericentric alpha satellite D5Z1; 5′-TTTTTGTGCAATTGGCAAATGGAG and 5′-AGACTGTTTCCTCACTGCTCT for pericentric alpha satellite D5Z2 (27) . JMJD2b promoter −1.8 kb control primers: 5′-ACCAGTGTGCAGCTTTCCTTCTCT and 5′-AAATATCTCCCAACCGCTGAGCTAGG. JMJD2b −0.5 kb primers (bracketing the p53 binding site): 5′-GTCTCACGTACTCAGCCG and 5′-CACAGAGAGGAGCCAGTATTG. The readouts were normalized using 10% input chromatin for each sample. The experiments were repeated 3 or more times. The p-values were calculated using two-tailed Student's tTest and shown in the figures.
RNA isolation and quantitative PCR
Total RNA was extracted using the RNeasy Mini kit (Qiagen). cDNAs were prepared by reverse transcription of total RNA using the SuperScript ™ III First-Strand Synthesis System (Invitrogen). The products were used for real-time PCR using the following primers: 5′-CTCAAGTGTGTGCGTATCCTCAA and 5′-CCGGAGCAGCTCCCTTTC for SUV39H1; 5′-GGAAGCCACGAGCATCCTATG and 5′-GGAACTCTCGAACAGTCATGG for JMJD2a; 5′-GGGGAGGAAGATGTGAGTGA and 5′-GACGGCTTTTGGAGGGTAAT for JMJD2b; 5′-GAGTCAACGGATTTGGTCGT and 5′-GACAAGCTTCCCGTTCTCAG for GAPDH.
RNA interference (RNAi)
Cells were transfected with 100 nM control siRNA or 100 nM Smartpool JMJD2b siRNAs (Dharmacon) using RNAiMAX (Invitrogen) according to instructions from the supplier. After 48 h of transfection, cells were treated with IR and analyzed for protein expression or chromatin immuno precipitation.
Immunofluorescence staining
Cells cultured on chamber slides were fixed with acetone-methanol (1:1) for 5 min at room temperature, blocked with PBS+10% normal goat serum (NGS) for 20 min, and incubated with anti-γH2AX in PBS with 10% NGS for 2 h. The slides were washed with PBS+0.1% Triton X-100, incubated with FITC-goat-anti-mouse IgG in PBS+10% NGS for 2 h, washed with PBS+0.1% Triton X-100 and mounted. The number of γH2AX foci per nucleus was determined using the Image Pro Plus (Media Cybernetics; Bethesda, MD) v6.2 software, ~20 cells were analyzed for each condition.
Cell death and colony formation assays
Cell death was measured by MTS assay using the Cell Titer kit (Promega). Five thousand cells were cultured in 24-well plates and treated with compounds for 72 h. Culture medium was replaced with fresh medium containing the MTS reagent and the cells were cultured for 15-30 min. Conversion of MTS reagent into color-absorbing product by metabolically active cells were measured by determining OD at 490 nm. For colony formation assay, five thousand cells were seeded in a 10-cm plate in triplicate, incubated for 8 h to allow attachment, treated with IR, and cultured for 7-10 days. After incubation, cells were washed with PBS, stained with 0.5% crystal violet for 1 min at 23°C, washed with PBS, and photographed for colony density. To quantify surviving cells, the crystal violet in stained colonies were extracted by incubation with 10% acetic acid for 20 min, absorbance at 590 nm was measured. A model of p53 promotion of heterochromatin DNA repair by regulating H3 K9 methylation level after damage.
